Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Strain-induced fully coherent triphase nanoarchitecture in refractory high-entropy alloys.

Science (New York, N.Y.)·2026
Same author

BalancedDiff: Balanced Diffusion Network for High-Quality Molecule Generation.

Journal of chemical information and modeling·2025
Same author

miR-199b-5p Regulates Immune-Mediated Allograft Rejection after Lung Transplantation Through the GSK3β and NF-κB Pathways.

Inflammation·2018
Same author

A signature based on survival-related genes identifies high-risk glioblastomas harboring immunosuppressive and aggressive ECM characteristics.

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences·2018
Same author

Curcumin enhances anti-tumor immune response in tongue squamous cell carcinoma.

Archives of oral biology·2018
Same author

Analyses of risk factors for polycystic ovary syndrome complicated with non-alcoholic fatty liver disease.

Experimental and therapeutic medicine·2018
Same journal

Predicting piRNA-Disease Associations Based on Dual-View Learning and Multi-head Self-Attention Mechanism Fusion.

Interdisciplinary sciences, computational life sciences·2026
Same journal

STNMAE: Identifying Spatial Domains from Spatial Transcriptomics Data with Neighbor-Aware Multi-view Masked Graph Autoencoder.

Interdisciplinary sciences, computational life sciences·2026
Same journal

Diagnosis and Prediction of Alzheimer's Disease via a High-Level Convolutional Block Attention Module-Residual Network.

Interdisciplinary sciences, computational life sciences·2026
Same journal

Deep3D-DTA: A Tri-Modal Deep Learning Framework for Binding Affinity Prediction Leveraging 3D Structural Representations of Drugs and Targets.

Interdisciplinary sciences, computational life sciences·2026
Same journal

ST-LDAW: A Topic-Model and Damped Weighted Least-Squares Method for Integrative Deconvolution of Single-Cell and Spatial Transcriptomics.

Interdisciplinary sciences, computational life sciences·2026
Same journal

MeDiCNet: Integrating Multi-scale Dynamic Convolution and Enhanced Position-Aware Transformer for DNA Methylation Site Prediction.

Interdisciplinary sciences, computational life sciences·2026
See all related articles

Related Experiment Video

Updated: Jun 19, 2026

Protein Target Prediction and Validation of Small Molecule Compound
10:21

Protein Target Prediction and Validation of Small Molecule Compound

Published on: February 23, 2024

DTANet+: Dual Interaction and Kernel-Diverse Network for Drug-Target Affinity Prediction.

Jin Xie1, Junxiong Li1, Yulong Wu1

  • 1School of Big Data and Software Engineering, Chongqing University, Chongqing, 400044, China.

Interdisciplinary Sciences, Computational Life Sciences
|June 17, 2026
PubMed
Summary
This summary is machine-generated.

We developed DTANet+, a deep learning framework for predicting drug-target binding affinity (DTA). DTANet+ incorporates biochemical knowledge to improve accuracy, aiding drug repositioning and personalized medicine.

Keywords:
Convolutional neural networkDrug-target binding affinityDual interactionKernel-diverse network

More Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Related Experiment Videos

Last Updated: Jun 19, 2026

Protein Target Prediction and Validation of Small Molecule Compound
10:21

Protein Target Prediction and Validation of Small Molecule Compound

Published on: February 23, 2024

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Area of Science:

  • Computational chemistry
  • Bioinformatics
  • Machine learning

Background:

  • Drug-target binding affinity (DTA) prediction is crucial for drug design but limited by costly assays.
  • Current computational methods often lack biochemical insights, hindering performance.

Purpose of the Study:

  • To introduce DTANet+, a novel deep learning framework for enhanced DTA prediction.
  • To integrate biochemical properties and binding site information into DTA prediction models.

Main Methods:

  • Developed DTANet+, a deep learning framework incorporating Kernel-diverse Feature Extraction Block (KFEB), Cross-Scale Interaction Module (CSIM), Drug-Target Interaction Module (DTIM), and Multi-modal Fusion Module (MFM).
  • Utilized KFEB and CSIM to extract features from functional groups and peptide chains.
  • Employed DTIM to analyze drug-target binding sites and MFM for information integration.

Main Results:

  • DTANet+ demonstrated superior performance on KIBA and Davis datasets.
  • Achieved higher Concordance Index (CI) and lower Mean Squared Error (MSE) compared to existing methods.
  • Validated the framework's effectiveness in DTA prediction.

Conclusions:

  • DTANet+ effectively integrates biochemical knowledge for accurate DTA prediction.
  • The framework shows significant potential for accelerating drug repositioning and enabling personalized medicine.
  • Publicly available source code facilitates further research and application.